Back
Organon & 10K Form
Sell
28
OGN
Organon &
Last Price:
14.51
Seasonality Move:
10.44%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive OGN News And Ratings
See the #1 stock for the next 7 days that we like better than OGN
OGN Financial Statistics
Sales & Book Value
| Annual Sales: | $6.26B |
|---|---|
| Cash Flow: | $65M |
| Price / Cash Flow: | 5.91 |
| Annual Sales: | $1.91 |
| Price / Book: | 7.72 |
Profitability
| EPS (TTM): | 5.04000 |
|---|---|
| Net Income (TTM): | $1.3B |
| Gross Margin: | $3.75B |
| Return on Equity: | 25019.23% |
| Return on Assets: | 10.87% |
Organon & Earnings Forecast
Key Organon & Financial Ratios
- The Gross Profit Margin over the past 6 years for OGN is 59.84%.
- The Selling, General & Administrative Expenses for OGN have been equal to 30.23% of Gross Profit Margin.
- The Research & Development expenses have been 8.43% of Revenue.
- The Interest Expense is 51.52% of Operating Income.
- The Net Earning history of OGN is 16.33% of Total Revenues.
- Per Share Earnings over the last 6 years have been positive in 2 years.
Organon & Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | OGN |
| Website: | organon.com |
Debt
| Debt-to-Equity Ratio: | 17.75 |
|---|---|
| Current Ratio: | 1.7 |
| Quick Ratio: | 0.88 |
Price-to-Earnings
| Trailing P/E Ratio: | 3.7 |
|---|---|
| Forward P/E Ratio: | 3.54 |